-

Vizient to Present at FDA CDER Quality Management Maturity Workshop

IRVING, Texas--(BUSINESS WIRE)--Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop, which is being held May 24-25, 2022. The two-day workshop will highlight the FDA’s work to develop a QMM rating program that will objectively assess and rate the QMM of facilities manufacturing drug products and active pharmaceutical ingredients.

On the second day of the workshop titled, “Development and Impact of Quality Ratings Systems,” Kistner will share Vizient’s efforts to support a more resilient supply chain and how group purchasing organizations could utilize QMM ratings.

“A QMM rating system will promote greater transparency of the maturity of quality management practices of drug manufacturers, which will help to address supply chain issues and mitigate drug shortages so that patients have access to critical drugs when they need them,” said Dan Kistner, group senior vice president, pharmacy solutions. “We commend the FDA for its commitment to ensuring that high-quality drugs are available for patients and for providing this forum to foster collaboration to end drug shortages. We need all stakeholders working together to increase supply chain resiliency.”

Kistner will join key FDA and pharmacy leaders on a Q&A panel to conclude the session.

Concurrent to the QMM Workshop, the FDA is soliciting input from stakeholders until June 7, 2022 that will help to inform the future regulatory approach for a Quality Metrics Reporting Program to which Vizient plans to share comments.

About Vizient, Inc.

Vizient, Inc., the nation’s largest health care performance improvement company, serves more than 50% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 20% of ambulatory care providers. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient’s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Vizient, Inc.


Release Summary
Vizient Group SVP Dan Kistner will present at the FDA Center for Drug Evaluation and Research Quality Management Maturity Workshop, May 25, 2022.
Release Versions

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Social Media Profiles
More News From Vizient, Inc.

Byron Jobe Recognized as One of Modern Healthcare’s 100 Most Influential People in Healthcare

IRVING, Texas--(BUSINESS WIRE)--This recognition acknowledges individuals who are deemed to be the most influential figures in the industry in terms of leadership and impact....

New Data Show Hospitals Continue to Improve Performance on Key Patient Safety Measures and Outcomes in 2025

WASHINGTON & IRVING, Texas--(BUSINESS WIRE)--Patient safety throughout health systems across the nation continue to improve, according to the American Hospital Association (AHA) and Vizient®....

Vizient Applauds FDA’s Recent Actions to Accelerate Biosimilar Development and Lower Costs

IRVING, Texas--(BUSINESS WIRE)--Vizient® commends the FDA for announcing actions to accelerate biosimilar development, including greater clarity for comparative efficacy studies....
Back to Newsroom